English | 简体中文 | 繁體中文 | 한국어
Share:
Sequa Petroleum N.V. (the "Company") General Meeting Results 8 December 2017
YASTEST Sequa Petroleum N.V. (the "Company") General Meeting Results 8 December 2017

11th December 2017

Sequa Petroleum N.V. (the "Company") General Meeting Results 8 December 2017

 

 The Company confirms that at its General Meeting held on 8 December in Amsterdam, all resolutions were passed by attending shareholders representing 39.00% of the issued share capital of the Company.

 

 

Contacts:

 Jacob Broekhuijsen - CEO

 +44(0)203-728-4450 or info@sequa-petroleum.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Sequa Petroleum NV via Globenewswire

Copyright © Thomson Reuters 2018. All rights reserved.
Press Releases
TiGenix: Transparency notification pursuant to Article 14 of the Law of May 2, 2007  
Jan 18, 2018 22:00 ET
GOGL - Issuance of new shares in connection with delivery of vessel  
Jan 18, 2018 19:50 ET
ASM INTERNATIONAL N.V. ANNOUNCES AVAILABILITY AND TIMING OF THE FOURTH QUARTER 2017 CONFERENCE CALL AND WEBCAST  
Jan 18, 2018 15:00 ET
XPO Logistics Extends Tuition-Free, Earn-While-You-Learn Driver Training  
Jan 18, 2018 14:30 ET
Sampo plc: Disclosure Under Chapter 9 Section 5 of the Securities Market Act (BlackRock, Inc.)  
Jan 18, 2018 14:15 ET
Eastman Schedules Fourth-Quarter and Full-Year 2017 Financial Results News Release and SEC Form 8-K Filing, Teleconference and Webcast  
Jan 12, 2018 03:03 ET
AIR Worldwide Estimates Insured Losses from Winter Storm Eleanor/Burglind Will Be Between EUR 1.1 Billion and EUR 1.6 Billion  
Jan 11, 2018 23:33 ET
NANOBIOTIX partners with the Providence Cancer Institute to run immunotherapeutic preclinical research in pancreatic cancers  
Jan 11, 2018 15:13 ET
INGREDION TO APPOINT ELIZABETH ADEFIOYE SENIOR VICE PRESIDENT AND CHIEF HUMAN RESOURCES OFFICER  
Jan 8, 2018 23:43 ET
CELIXIR: CTA approval for potentially pivotal HeartcelTM Phase IIb trial  
Jan 8, 2018 21:03 ET
More News >>
Copyright © 2018 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: